Advances in Psychedelic Medicine: State-of-the-Art Therapeutic Applications

Advances in Psychedelic Medicine: State-of-the-Art Therapeutic Applications

by Michael J. Winkelman, Ben Sessa MD

NOOK Book(eBook)

$63.99 $73.00 Save 12% Current price is $63.99, Original price is $73. You Save 12%.
View All Available Formats & Editions

Available on Compatible NOOK Devices and the free NOOK Apps.
WANT A NOOK?  Explore Now


Researchers, program administrators, and practicing clinicians explain the most recent developments in using psychedelic substances to treat psychological, physiological, and social problems.

• Describes the history of psychedelics as therapeutic treatments and the current renaissance of interest in them

• Details the training of therapists in applications of psychedelics, and medical theory for the effectiveness of these substances

• Addresses issues of clinical efficacy and safety as well as ethical considerations

• Comprises the latest neuroscience research related to the effects of the psychedelic compounds

• Provides timely information for clinicians, researchers, and advanced students of psychology, medicine, and public health, from leading clinicians, researchers, and administrators in the field

Product Details

ISBN-13: 9781440864117
Publisher: ABC-CLIO, Incorporated
Publication date: 03/22/2019
Sold by: Barnes & Noble
Format: NOOK Book
Pages: 386
File size: 910 KB

About the Author

Michael Winkelman, PhD, is retired from the School of Human Evolution and Social Change at Arizona State University, where he served as director of the medical anthropology program.

Ben Sessa, MD, is a consultant child and adolescent psychiatrist working in adult addiction services and with PTSD in veterans.

Table of Contents

Acknowledgments ix

Chapter 1 Introduction: The Psychedelic Renaissance Continues Michael Winkelman Ben Sessa 1

Part 1 Psychiatry 1

Chapter 2 Psychedelics and Psychiatry: A New Treatment Model for the 21st Century Charles S. Grob Gary Bravo 13

Chapter 3 Therapeutic Applications of 3,4-methylenedioxymethamphetamine (MDMA) Ben Sessa 38

Chapter 4 Psilocybin Therapy for Major Depressive Disorder James JH Rucker 59

Chapter 5 Ketamine Therapy for Treatment-Resistant Depression L. Alison McInnes Marc Ettensohn 81

Chapter 6 Evidence for the Therapeutic Effects of Ayahuasca Dráulio Barros de Araújo 102

Part 2 Substance Abuse 125

Chapter 7 Psilocybin for the Treatment of Substance Use Disorders Ishani Rao Greg Lydall 127

Chapter 8 Potential Applications of Cannabis and Cannabinoids in the Treatment of Substance Use Disorder and in Harm Reduction José Carlos Bouso Rafael Guimaraes dos Santos Jaime Hallak 148

Chapter 9 Psychedelic Therapy as a Complementary Treatment Approach for Alcohol Use Disorders Peter Eischens William Leigh Atherton 170

Part 3 Medical Hypotheses 191

Chapter 10 Effects of Psychedelics on Inflammation and Immunity Attila Szabo 193

Chapter 11 The Protective Rule of Dimethyltryptamine against Ischemia-Reperfusion Injury Ede Frecska Attila Istvan Kovacs Attila Szabo 214

Chapter 12 Psychedelic Treatment of Disruptive Personality Patterns Petr Winkler Rita Kocárová 232

Part 4 Treatment and Training 251

Chapter 13 Guidelines in Applying Psychedelic Therapies Friederike Meckel 253

Chapter 14 Training Psychedelic Therapists Janis Phelps 274

Part 5 Societal Engagement with Psychedelics 295

Chapter 15 Community-Based Full-Spectrum Harm Reduction Approaches When Caring for Psychoactive- and Psychedelic-Related Problems at a Transformational Festival Maria Carmo Carvalho Cristiana Vale Pires Ana Luisa Costa Daniel Martins Helena Valente Ines Macedo Paula Frango Raquel Lira 297

Chapter 16 Microdosing Psychedelics James Fadiman Sophia Korb 318

Chapter 17 Bringing Psychedelics and Entactogens into Mainstream Pharmaceuticals: A Focus on MDMA Anne C. Wagner Michael C. Mithoefer Rick Doblin 336

About the Editors and Contributors 357

Index 371

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews